Kolkata, India

Kausik Paul

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Council of Scientific and Industrial Research. Active years: 2016.

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 15.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kausik Paul: Innovator in Cancer Treatment

Introduction

Kausik Paul is a notable inventor based in Kolkata, India. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the inhibition of specific pathways that are crucial in the progression of malignancies.

Latest Patents

Kausik Paul holds a patent for "Inhibitors of phosphatidylinositol-3-kinase (PI3) and inducers of nitric oxide (NO)." This invention relates to compounds of general formula 1 that are designed for the treatment of malignancy by inhibiting the PI3-Akt pathway and/or inducing nitric oxide. The patent outlines a method of treating malignancy through the administration of these compounds to mammals in need of such treatment. He has 1 patent to his name.

Career Highlights

Kausik Paul is affiliated with the Council of Scientific & Industrial Research, where he conducts his research. His work has been instrumental in advancing the understanding of cancer treatment methodologies. He has dedicated his career to exploring innovative solutions for complex medical challenges.

Collaborations

Kausik has collaborated with notable colleagues such as Santu Bandyopadhyay and Bikas Chandra Pal. Their combined expertise has contributed to the success of various research projects and innovations in the field.

Conclusion

Kausik Paul's contributions to cancer treatment through his innovative patents and research highlight his commitment to improving healthcare outcomes. His work continues to inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…